Primary Genes Promoting Cementoblast Differentiaton
促进成牙骨质细胞分化的初级基因
基本信息
- 批准号:6747942
- 负责人:
- 金额:$ 36.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Periodontal regeneration is an important, yet unattainable, treatment objective in dentistry. Developing better regenerative treatments requires a deeper understanding of cementoblast, osteoblast, and PDL fibroblast biology. The recently established OC-CM cementoblastic cell line provides an invaluable research tool for studying cementoblast molecular biology. We found that prostaglandin (PG) E2 and fluprostenol (flup; a specific FP receptor agonist) promoted, while interleukin-1 (IL-1) inhibited, OC-CM mineralization and differentiation. These effects were reproducible in primary human cementoblasts. Mechanistically, receptor bound flup and IL-1 induce primary genes, which regulate downstream genes and ultimately control cell function. Some primary genes are induced by both flup and IL-I, while others are preferentially induced by each treatment. We hypothesize that preferentially induced primary genes dictate flup- and IL-l-regulated cementoblast function. To identify primary genes we performed subtraction hybridization using OC-CM cells treated with 0.1 (M flup or 10 ng/ml IL-1 for 90 min. Two cDNA subtractions were performed: (a) flup - IL-l, to identify flup-induced genes and (b) IL-1 - flup, to identify IL-l-induced genes. Several preferentially induced primary genes were identified. Our objective is to study the role of the transcription factors Nur77 and egr1, and the MAP kinase signaling regulator mkp1 in cementoblast function. In preliminary studies, mRNA from all three genes was rapidly and transiently induced by flup, but not by IL-1, in OC-CM cells. This temporal pattern of Nur77, egr1, and mkp1 mRNA expression was replicated in primary human cementoblasts and primary mouse osteoblasts treated with flup. We propose three Specific Aims: 1) to characterize Nur77, egr1, and mkp1 gene regulation by prostanoids in cementoblasts, 2) to characterize Nur77, egr1, and mkp1 protein involvement in regulating cementoblast gene expression and differentiation, and 3) to examine PGE2 and PGF2alpha induction of Nur77, egr1, and mkp1 gene expression in cementoblasts in vivo. We anticipate that Nur77, egr1, and mkp1 will be key mediators of cementoblast differentiation. These studies will contribute to our understanding of the molecular signals that regulate cementoblast function.
描述(由申请人提供):牙周再生是牙科领域一个重要但难以实现的治疗目标。开发更好的再生治疗需要更深入地了解成牙骨质细胞,成骨细胞和PDL成纤维细胞生物学。最近建立的OC-CM成牙骨质细胞系为研究成牙骨质细胞分子生物学提供了一个宝贵的研究工具。我们发现,前列腺素(PG)E2和氟前列醇(flup;一种特异性FP受体激动剂)促进,而白细胞介素-1(IL-1)抑制,OC-CM矿化和分化。这些效应在原代人成牙骨质细胞中可重现。在机制上,受体结合的flup和IL-1诱导初级基因,其调节下游基因并最终控制细胞功能。一些主要基因被flup和IL-1诱导,而其他基因被每种处理优先诱导。我们假设优先诱导的初级基因决定flup和IL-1调节的成牙骨质细胞功能。为了鉴定初级基因,我们使用用0.1 μ M flup或10 ng/ml IL-1处理90分钟的OC-CM细胞进行消减杂交。进行两次cDNA消减:(a)flup-IL-1,以鉴定flup诱导的基因,和(B)IL-1-flup,以鉴定IL-1诱导的基因。几个优先诱导的主要基因进行了鉴定。我们的目的是研究转录因子Nur77和egr 1以及MAP激酶信号调节因子mkp 1在成牙骨质细胞功能中的作用。在初步研究中,来自所有三个基因的mRNA在OC-CM细胞中被flup快速和瞬时诱导,但不被IL-1诱导。Nur77,egr 1和mkp 1 mRNA表达的时间模式在用flup处理的原代人成牙骨质细胞和原代小鼠成骨细胞中复制。我们提出了三个具体目标:1)表征成牙骨质细胞中前列腺素类对Nur77、egr 1和mkp 1基因的调控,2)表征Nur77、egr 1和mkp 1蛋白参与调控成牙骨质细胞基因表达和分化,3)研究体内PGE2和PGF2 α对成牙骨质细胞中Nur77、egr 1和mkp 1基因表达的诱导作用。我们预期Nur77、egr 1和mkp 1将是成牙骨质细胞分化的关键介质。这些研究将有助于我们了解调节成牙骨质细胞功能的分子信号。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SOTIRIOS TETRADIS其他文献
SOTIRIOS TETRADIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SOTIRIOS TETRADIS', 18)}}的其他基金
Pathophysiologic Mechanisms of Bisphosphonate Related Osteonecrosis of the Jaws
双膦酸盐相关颌骨骨坏死的病理生理机制
- 批准号:
8893945 - 财政年份:2009
- 资助金额:
$ 36.22万 - 项目类别:
Pathophysiologic mechanisms during initiation of medication related osteonecrosis of the jaws
药物相关颌骨骨坏死起始过程中的病理生理机制
- 批准号:
10466925 - 财政年份:2009
- 资助金额:
$ 36.22万 - 项目类别:
Pathophysiologic Mechanisms of Bisphosphonate Related Osteonecrosis of the Jaws
双膦酸盐相关颌骨骨坏死的病理生理机制
- 批准号:
9115565 - 财政年份:2009
- 资助金额:
$ 36.22万 - 项目类别:
Pathophysiologic mechanisms during initiation of medication related osteonecrosis of the jaws
药物相关颌骨骨坏死起始过程中的病理生理机制
- 批准号:
10264918 - 财政年份:2009
- 资助金额:
$ 36.22万 - 项目类别:
Pathophysiologic Mechanisms of Bisphosphonate Related Osteonecrosis of the Jaws
双膦酸盐相关颌骨骨坏死的病理生理机制
- 批准号:
8761983 - 财政年份:2009
- 资助金额:
$ 36.22万 - 项目类别:
Pathophysiologic mechanisms during initiation of medication related osteonecrosis of the jaws
药物相关颌骨骨坏死起始过程中的病理生理机制
- 批准号:
10119690 - 财政年份:2009
- 资助金额:
$ 36.22万 - 项目类别:
Pathophysiologic mechanisms during initiation of medication related osteonecrosis of the jaws
药物相关颌骨骨坏死起始过程中的病理生理机制
- 批准号:
10686877 - 财政年份:2009
- 资助金额:
$ 36.22万 - 项目类别:
Primary Genes Promoting Cementoblast Differentiaton
促进成牙骨质细胞分化的初级基因
- 批准号:
6936009 - 财政年份:2003
- 资助金额:
$ 36.22万 - 项目类别:
Primary Genes Promoting Cementoblast Differentiaton
促进成牙骨质细胞分化的初级基因
- 批准号:
7235626 - 财政年份:2003
- 资助金额:
$ 36.22万 - 项目类别:
Primary Genes Promoting Cementoblast Differentiaton
促进成牙骨质细胞分化的初级基因
- 批准号:
6598577 - 财政年份:2003
- 资助金额:
$ 36.22万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 36.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 36.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 36.22万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 36.22万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 36.22万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 36.22万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 36.22万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 36.22万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 36.22万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 36.22万 - 项目类别:
Studentship